Kimberly Ha | Head of Investor Relations |
Jennifer Buell | President and Chief Executive Officer |
Christine Klaskin | Principal Financial and Accounting Officer |
Kalpit Patel | B. Riley Securities |
Jack Allen | Baird |
Matthew Phipps | William Blair |
Good day, and welcome to the MiNK Therapeutics Second Quarter 2022 Earnings Conference Call. Please note, today's conference call is being recorded. All lines have been placed on mute to prevent any background noise. After the speakers' remarks there will be a question-and-answer session. [Operator Instructions] Thank you.